| 12187816 |
Macrocyclic compounds and methods of use thereof |
Jakob FUHRMANN, Hao Wu, Jeremy M. Murray |
2025-01-07 |
|
| 11666581 |
PROTAC antibody conjugates and methods of use |
Thomas Pillow, Jack Sadowsky, Leanna Staben, Steven Staben, BinQing Wei +4 more |
2023-06-06 |
|
| 11590128 |
Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor |
Deepak Sampath, Christian Klein, Sari L. Heitner Enschede, Rod A. Humerickhouse, Andrew W. Roberts +1 more |
2023-02-28 |
|
| 11413282 |
Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor |
Deepak Sampath, Christian Klein |
2022-08-16 |
|
| 11110087 |
Combination therapy of a type II anti-CD20 antibody with a selective Bcl-2 inhibitor |
Deepak Sampath, Christian Klein, Sari L. Heitner Enschede, Rod A. Humerickhouse, Andrew W. Roberts +1 more |
2021-09-07 |
|
| 10993942 |
Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor |
Deepak Sampath, Christian Klein, Sari L. Heitner Enschede, Rod A. Humerickhouse, Andrew W. Roberts +1 more |
2021-05-04 |
|
| 9539251 |
Combination therapy of a type II anti-CD20 antibody with a selective Bcl-2 inhibitor |
Deepak Sampath, Christian Klein |
2017-01-10 |
|
| 9067928 |
Compounds and methods of use |
Jonathan Bayldon Baell, Chinh Thien Bui, Peter Colman, Danette Dudley, John A. Flygare +11 more |
2015-06-30 |
$93,334,000 |
| 8980837 |
Inhibitors of IAP |
Frederick Cohen, Kurt Deshayes, Bainian Feng, John A. Flygare, Lewis Gazzard +1 more |
2015-03-17 |
|
| 8518970 |
Compounds and methods of use |
Jonathan Bayldon Baell, Chinh Thien Bui, Peter Colman, Danette Dudley, John A. Flygare +11 more |
2013-08-27 |
$127,881,000 |
| 8232273 |
Heterocyclic compounds and methods of use |
Jonathan Bayldon Baell, Chinh Thien Bui, Peter Colman, Peter Edward Czabotar, Danette Dudley +15 more |
2012-07-31 |
$42,316,000 |
| 8168645 |
Arylsulfonamide compounds |
Jonathan Bayldon Baell, Guillaume Laurent Lessene, Brad Sleebs, John A. Flygare, Michael F. T. Koehler |
2012-05-01 |
|
| 8114893 |
Compounds and methods of use |
Jonathan Bayldon Baell, Chinh Thien Bui, Peter Colman, Danette Dudley, John A. Flygare +11 more |
2012-02-14 |
$29,968,000 |
| 8110568 |
Inhibitors of IAP |
Frederick Cohen, Kurt Deshayes, Bainian Feng, John A. Flygare, Lewis Gazzard +1 more |
2012-02-07 |
|
| 7563583 |
Heregulin variants |
Marcus Ballinger, Jennifer T. Jones, Mark S Sliwkowski, James A. Wells |
2009-07-21 |
|
| 7399869 |
Fibroblast activation protein inhibitor compounds and methods |
Frederick Cohen, Clifford Quan, Daniel P. Sutherlin, Beni B. Wolf |
2008-07-15 |
$147,919,000 |
| 7345081 |
Azabicyclo-octane inhibitors of IAP |
Frederick Cohen, John A. Flygare, Stephen Franz Keteltas, Vickie Hsiao-Wei Tsui |
2008-03-18 |
$67,492,000 |
| 7244851 |
Inhibitors of IAP |
Frederick Cohen, Kurt Deshayes, Bainian Feng, John A. Flygare, Lewis Gazzard +1 more |
2007-07-17 |
$66,327,000 |
| 7067274 |
Compositions and methods for the screening pro-apoptotic compounds |
Matthew C. Franklin, Heidi Jenii Ackerly Wallweber, Linda Elliott, Saloumeh Kadkhodayan, Domagoj Vucic +1 more |
2006-06-27 |
$119,091,000 |
| 7063961 |
Heregulin variants |
Marcus Ballinger, Jennifer T. Jones, Mark Sliwkowski, James A. Wells |
2006-06-20 |
$455,698,000 |
| 6387638 |
Heregulin variants |
Marcus Ballinger, Jennifer T. Jones, Mark Sliwkowski, James A. Wells |
2002-05-14 |
$42,424,000 |
| 6136558 |
Heregulin variants |
Marcus Ballinger, Jennifer T. Jones, Mark Sliwkowski, James A. Wells |
2000-10-24 |
$168,095,000 |
